Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENLAFAXINE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 11 adverse event reports in the FDA FAERS database where VENLAFAXINE was used for Psoriasis.

Most Reported Side Effects for VENLAFAXINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 5,408 11.3% 156 1,052
Toxicity to various agents 3,917 8.2% 2,179 1,892
Nausea 2,989 6.2% 257 624
Completed suicide 2,929 6.1% 2,914 920
Headache 2,668 5.6% 335 452
Dizziness 2,426 5.1% 229 476
Off label use 2,310 4.8% 227 637
Overdose 2,220 4.6% 592 1,154
Intentional overdose 2,187 4.6% 196 1,597
Fatigue 2,153 4.5% 302 505
Anxiety 2,059 4.3% 64 559
Hyperhidrosis 1,932 4.0% 117 348
Depression 1,921 4.0% 102 560
Suicide attempt 1,893 4.0% 53 1,181
Drug interaction 1,860 3.9% 270 859

Other Indications for VENLAFAXINE

Product used for unknown indication (15,609) Depression (11,868) Anxiety (2,564) Major depression (1,380) Bipolar disorder (757) Migraine (706) Suicide attempt (475) Anxiety disorder (443) Antidepressant therapy (441) Generalised anxiety disorder (317)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

VENLAFAXINE Full Profile All Psoriasis Drugs VENLAFAXINE Demographics VENLAFAXINE Timeline